Biophysical characterization of SARS-CoV-2 spike protein - receptor interactions
Biophysical characterization of SARS-CoV-2 spike protein - receptor interactions
批准号:
10445350
负责人:
Wonpil Im
金额:
$22.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-06 至 2024-06-30
关键词:
2019-nCoVACE2AffinityAngiotensin ReceptorAntiviral TherapyBindingBiological AssayBiophysical ProcessBiophysicsCD209 geneCOVID-19COVID-19 complicationsCOVID-19 pandemicCell Surface ProteinsCell Surface ReceptorsCell membraneCellsCellular MembraneCessation of lifeClinical ResearchClinical TrialsComplexCountryDataDetectionEbola virusEnzymesFDA approvedGlycoproteinsHumanImmobilizationIndividualKineticsLengthMechanicsMediatingMembraneMembrane FusionMembrane ProteinsModelingMutationNRP1 geneNeuropilin-1Pathway interactionsPharmaceutical PreparationsPhysiologicalPolysaccharidesPositioning AttributeProtein DynamicsProteinsReportingResearchResearch PersonnelRouteSARS-CoV-2 antiviralSARS-CoV-2 infectionSARS-CoV-2 spike proteinSerine ProteaseSpectrum AnalysisStructural ModelsStructureSurfaceTMPRSS2 geneTechniquesTestingTimeTropismVaccinesViralVirionVirusWorkbasebiophysical propertiesdata modelingexperienceexperimental studymodels and simulationmolecular dynamicsmolecular modelingmonomernovelpandemic diseaseparticleprotein activationprotein structureprotein structure predictionreceptorreceptor bindingsimulationsingle moleculetissue tropismtooluptakevirus envelope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The current pandemic of Coronavirus Disease-2019 (COVID-19) has had devastating impacts across the world.
In order to enter human host cells, SARS-CoV-2, the virus causing COVID-19, uses its surface spike (S) protein
to attach to host cell surface receptors. Besides the best-known receptor, ACE2, a number of cell surface proteins,
including CD147, neuropilin-1 (NRP1) and DC-SIGN/L-SIGN, have been reported to bind to S protein and
mediate SARS-CoV-2 entry. Consistently, our preliminary studies using single-molecule force spectroscopy
show that CD147, NRP1 and L-SIGN can bind to the SARS-CoV-2 S protein with comparable affinities to those
of ACE2. Therefore, the possible multiple receptor utilization could, at least partially, explain the broad tissue
tropism and systemic complications of SARS-CoV-2 infection. However, it remains puzzling how the S protein
can bind to these structurally diverse molecules with high affinity. In addition, our all-atom structural modeling
data shows that most of the S protein surface is covered by glycans, and only when the S protein’s receptor
binding domain (RBD) is in the “up position” can it bind to a receptor without glycan interference. Therefore, we
hypothesize that limited regions on the S protein that are not covered by glycans, including the RBD in up position,
as well as the S1/S2 junctional region, may be responsible for binding all the receptors. In the proposed work,
we will systematically test the hypothesis using combined approaches of single-virus force spectroscopy, all-
atom molecular modeling and simulation and pseudovirus internalization/entry assays. Moreover, since SARS-
CoV-2 has two entry routes (direct viral-host membrane fusion or endocytic/macropinocytic internalization
followed by endosomal entry), the exact entry pathways that these receptors mediate are not yet clear. The
proposed research will determine whether every individual interaction is more prone to mediate direct viral-host
membrane fusion or viral endocytic/macropinocytic internalization. Two specific aims will be pursued: 1) to
characterize S protein interactions with host cell membrane receptors and 2) to determine the structural basis of
S protein’s broad receptor recognition. The study will elucidate the structural and biophysical mechanisms behind
S protein’s receptor recognition and utilization. Successful completion of this work will allow us to identify new
targets for antiviral therapies to treat the systemic complications of COVID-19.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy
冯·维勒布兰德因子/ADAMTS13 失衡对 COVID-19 凝血病的影响
DOI:
10.1152/ajpheart.00204.2021
发表时间:
2022
期刊:
American Journal of Physiology-Heart and Circulatory Physiology
影响因子:
4.8
作者:
[Seth, Ryan, McKinnon, Thomas A., Zhang, X. Frank]
通讯作者:
Zhang, X. Frank
Biophysical characterization of SARS-CoV-2 spike protein - receptor interactions
-
批准号:10286279
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2021
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10793784
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10447810
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10671554
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10386324
-
项目类别:
-
资助金额:$11.58万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10223386
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
CHARMM-GUI Development for Biomolecular Modeling and Simulation Community
-
批准号:10027337
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2020
-
负责人:Wonpil Im
-
依托单位:
Development of Computational Toolset for Structural Systems Pharmacology
-
批准号:9419966
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2018
-
负责人:Wonpil Im
-
依托单位:
Mechanisms & Energetics of Transmembrane-induced Signaling of Cytokine Receptors
-
批准号:8098698
-
项目类别:
-
资助金额:$27.99万
-
财政年份:2010
-
负责人:Wonpil Im
-
依托单位:
Mechanisms & Energetics of Transmembrane-induced Signaling of Cytokine Receptors
-
批准号:7862768
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2010
-
负责人:Wonpil Im
-
依托单位:
Mechanisms & Energetics of Transmembrane-induced Signaling of Cytokine Receptors
-
批准号:8501547
-
项目类别:
-
资助金额:$26.98万
-
财政年份:2010
-
负责人:Wonpil Im
-
依托单位:
Mechanisms & Energetics of Transmembrane-induced Signaling of Cytokine Receptors
-
批准号:8299076
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2010
-
负责人:Wonpil Im
-
依托单位:
Mechanisms & Energetics of Transmembrane-induced Signaling of Cytokine Receptors
-
批准号:8681468
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2010
-
负责人:Wonpil Im
-
依托单位:
MOLECULAR DYNAMICS STUDIES OF GATING MECHANISM OF MSCL AS A FUNCTION OF HELIX T
-
批准号:7956256
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Wonpil Im
-
依托单位:
UNDERSTANDING OF HYDROPHOBIC MISMATCH BY POTENTIALS OF MEAN FORCE CALCULATIONS
-
批准号:7956151
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Wonpil Im
-
依托单位:
NMR AND COMPUTATIONAL STUDIES OF PROTEIN TRANSLOCATION IN BACTERIAL NEEDLES
-
批准号:7959521
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2009
-
负责人:Wonpil Im
-
依托单位:
MOLECULAR DYNAMICS STUDIES OF GATING MECHANISM OF MSCL AS A FUNCTION OF HELIX T
-
批准号:7723397
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Wonpil Im
-
依托单位:
UNDERSTANDING OF HYDROPHOBIC MISMATCH BY POTENTIALS OF MEAN FORCE CALCULATIONS
-
批准号:7723271
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Wonpil Im
-
依托单位:
UNDERSTANDING OF HYDROPHOBIC MISMATCH BY POTENTIALS OF MEAN FORCE CALCULATIONS
-
批准号:7601534
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2007
-
负责人:Wonpil Im
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: